Genomics|Update|Non Communicable Diseases ► Cancer

Genomics|Update|Non Communicable Diseases

Volume 35  Number 10  September 3-10, 2015

Cancer

American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility 
Robson ME, et al. JCO.2015.63.0996

Genetic cancer susceptibility testing: Increased technology, increased complexity 
Yu PP, et al. JCO.2015.63.3628

Association between use of the 21-gene recurrence score assay and receipt of chemotherapy among Medicare beneficiaries with early-stage breast cancer, 2005-2009. 
Dinan MA et al. JAMA Oncol 2015 Aug 27.

Counselees' expressed level of understanding of the risk estimate and surveillance recommendation are not associated with breast cancer surveillance adherence. 
Albada A et al. J Genet Couns 2015 Sep 1.

EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust. 
Berg J et al. Acta Oncol 2015 Aug 27. 1-7

Improving patient outcomes with cancer genomics 
Schnepp RW, et al. JAMA. 2015;314(9):881-883.

Integrative clinical sequencing in the management of refractory or relapsed cancer in youth 
Moody RJ, et al. JAMA. 2015;314(9):913-925.

MSIplus: Integrated colorectal cancer molecular testing by next-generation sequencing. 
Hempelmann JA et al. J Mol Diagn 2015 Aug 28.

Molecular testing in anatomic pathology and adherence to guidelines: A College of American Pathologists Q-probes study of 2230 testing events reported by 26 institutions. 
Volmar KE et al. Arch. Pathol. Lab. Med. 2015 Sep 139(9) 1115-24

Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: A prospective investigation in the CAPP2 study. 
Movahedi M et al. J. Clin. Oncol. 2015 Aug 17.

Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories. 
Saam J et al. Oncology 2015 Aug 28.

Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study. 
Siebenhofer A et al. BMC Cancer 2015 15(1) 605

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. 
Hyman DM et al. Drug Discov. Today 2015 Aug 27.

Precision medicine in breast cancer care: An early glimpse of impact. 
Kurian AW et al. JAMA Oncol 2015 Aug 27.

Service delivery model and experiences in a cancer genetics clinic for an underserved population. 
Woodson AH et al. J Health Care Poor Underserved 2015 26(3) 784-91 

The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes. 
Zupan A et al. Exp. Mol. Pathol. 2015 Aug 27.

The influence of screening for precancerous lesions on family-based genetic association tests: An example of colorectal polyps and cancer. 
Schmit SL et al. Am. J. Epidemiol. 2015 Aug 24.